Trial
NCT04807829
Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicidal Ideation
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Suicidal Ideation
Intervention
Nabilone
Why stopped
The study was stopped due to drug unavailability. The drug is unavailable because production was discontinued in the US.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-22